Organization Profile

You just read:

Health Canada Approves INFLECTRA® (biosimilar Infliximab) for Three Additional Indications: Crohn's disease, fistulising Crohn's disease and ulcerative colitis

News provided by

PFIZER CANADA INC.

Jun 14, 2016, 15:01 ET